148 related articles for article (PubMed ID: 1997044)
21. Analgesic response and plasma and brain extracellular fluid pharmacokinetics of morphine and morphine-6-beta-D-glucuronide in the rat.
Stain F; Barjavel MJ; Sandouk P; Plotkine M; Scherrmann JM; Bhargava HN
J Pharmacol Exp Ther; 1995 Aug; 274(2):852-7. PubMed ID: 7636748
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic modeling of M6G formation after oral administration of morphine in healthy volunteers.
Lötsch J; Weiss M; Ahne G; Kobal G; Geisslinger G
Anesthesiology; 1999 Apr; 90(4):1026-38. PubMed ID: 10201674
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the pharmacokinetics, behavioral effects and effects on thermal nociception of morphine 6-glucuronide and morphine 3-glucuronide in horses.
Knych HK; Kanarr K; Fang Y; McKemie DS; Kass PH
Vet Anaesth Analg; 2022 Nov; 49(6):634-644. PubMed ID: 35999165
[TBL] [Abstract][Full Text] [Related]
24. Distribution of morphine 6-glucuronide and morphine across the blood-brain barrier in awake, freely moving rats investigated by in vivo microdialysis sampling.
Aasmundstad TA; Mørland J; Paulsen RE
J Pharmacol Exp Ther; 1995 Oct; 275(1):435-41. PubMed ID: 7562582
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic and pharmacodynamic study of morphine and morphine 6-glucuronide after oral and intravenous administration of morphine in children with cancer.
Mashayekhi SO; Ghandforoush-Sattari M; Routledge PA; Hain RD
Biopharm Drug Dispos; 2009 Apr; 30(3):99-106. PubMed ID: 19260034
[TBL] [Abstract][Full Text] [Related]
26. Studies on morphine disposition: influence of renal failure on the kinetics of morphine and its metabolites.
Sear JW; Hand CW; Moore RA; McQuay HJ
Br J Anaesth; 1989 Jan; 62(1):28-32. PubMed ID: 2644963
[TBL] [Abstract][Full Text] [Related]
27. Intestinal absorption and stability of morphine 6-glucuronide in different physiological compartments of the rat.
Stain-Texier F; Sandouk P; Scherrmann JM
Drug Metab Dispos; 1998 May; 26(5):383-7. PubMed ID: 9571218
[TBL] [Abstract][Full Text] [Related]
28. Clinical pharmacokinetics of morphine and its metabolites during morphine dose titration for chronic cancer pain.
De Gregori S; Minella CE; De Gregori M; Tinelli C; Ranzani GN; Govoni S; Allegri M; Regazzi M
Ther Drug Monit; 2014 Jun; 36(3):335-44. PubMed ID: 24595069
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine.
Meineke I; Freudenthaler S; Hofmann U; Schaeffeler E; Mikus G; Schwab M; Prange HW; Gleiter CH; Brockmöller J
Br J Clin Pharmacol; 2002 Dec; 54(6):592-603. PubMed ID: 12492606
[TBL] [Abstract][Full Text] [Related]
30. Probenecid interacts with the pharmacokinetics of morphine-6-glucuronide in humans.
Skarke C; Langer M; Jarrar M; Schmidt H; Geisslinger G; Lötsch J
Anesthesiology; 2004 Dec; 101(6):1394-9. PubMed ID: 15564947
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal dialysis.
Pauli-Magnus C; Hofmann U; Mikus G; Kuhlmann U; Mettang T
Nephrol Dial Transplant; 1999 Apr; 14(4):903-9. PubMed ID: 10328468
[TBL] [Abstract][Full Text] [Related]
32. Morphine-6-glucuronide: potency and safety compared with morphine.
van Dorp EL; Morariu A; Dahan A
Expert Opin Pharmacother; 2008 Aug; 9(11):1955-61. PubMed ID: 18627332
[TBL] [Abstract][Full Text] [Related]
33. Lack of effect of ondansetron on the pharmacokinetics and analgesic effects of morphine and metabolites after single-dose morphine administration in healthy volunteers.
Crews KR; Murthy BP; Hussey EK; Passannante AN; Palmer JL; Maixner W; Brouwer KL
Br J Clin Pharmacol; 2001 Apr; 51(4):309-16. PubMed ID: 11318765
[TBL] [Abstract][Full Text] [Related]
34. Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide.
Klimas R; Mikus G
Br J Anaesth; 2014 Dec; 113(6):935-44. PubMed ID: 24985077
[TBL] [Abstract][Full Text] [Related]
35. The influence of renal function on the renal clearance of morphine and its glucuronide metabolites in intensive-care patients.
Milne RW; Nation RL; Somogyi AA; Bochner F; Griggs WM
Br J Clin Pharmacol; 1992 Jul; 34(1):53-9. PubMed ID: 1633068
[TBL] [Abstract][Full Text] [Related]
36. Morphine and morphine-6-glucuronide in the plasma and cerebrospinal fluid of children.
Hain RD; Hardcastle A; Pinkerton CR; Aherne GW
Br J Clin Pharmacol; 1999 Jul; 48(1):37-42. PubMed ID: 10383558
[TBL] [Abstract][Full Text] [Related]
37. Plasma concentrations and renal clearance of morphine, morphine-3-glucuronide and morphine-6-glucuronide in cancer patients receiving morphine.
Somogyi AA; Nation RL; Olweny C; Tsirgiotis P; van Crugten J; Milne RW; Cleary JF; Danz C; Bochner F
Clin Pharmacokinet; 1993 May; 24(5):413-20. PubMed ID: 8504624
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a differential radioimmunoassay technique for the determination of morphine and morphine-6-glucuronide in human plasma.
Chapman DJ; Joel SP; Aherne GW
J Pharm Biomed Anal; 1994 Mar; 12(3):353-60. PubMed ID: 8031935
[TBL] [Abstract][Full Text] [Related]
39. Influence of renal failure on the disposition of morphine, morphine-3-glucuronide and morphine-6-glucuronide in sheep during intravenous infusion with morphine.
Milne RW; McLean CF; Mather LE; Nation RL; Runciman WB; Rutten AJ; Somogyi AA
J Pharmacol Exp Ther; 1997 Aug; 282(2):779-86. PubMed ID: 9262341
[TBL] [Abstract][Full Text] [Related]
40. Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in the sheep.
Milne RW; Sloan PA; McLean CF; Mather LE; Nation RL; Runciman WB; Rutten AJ; Somogyi AA
Drug Metab Dispos; 1993; 21(6):1151-6. PubMed ID: 7905398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
